Suppression of PI3K/mTOR pathway rescues LLC cells from cell death induced by hypoxia

Biochemical and Biophysical Research Communications

Volumn 330, Issue 1, 2005, Pages 318-326

  Hamanaka, Y ^a,b   Mukai, M ^a   Shimamura, M ^a   Kitagawa, T ^b   Nishida, T ^b   Isohashi, F ^a   Ito, T ^b   Nishizawa, Y ^a   Tatsuta, M ^a   Matsuda, H ^b   Inoue, M ^a  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

ATP; Cancer; Cell cycle; Hypoxia resistance; mTOR; Necrosis; PI3K; S6; S6K

Indexed keywords

ADENOSINE TRIPHOSPHATE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; S6 KINASE;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL DEATH; CONTROLLED STUDY; ENZYME INHIBITION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HYPOXIA; LUNG CARCINOMA; MOUSE; NECROSIS; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REDUCTION;

EID: 20144373640     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.02.163     Document Type: Article

References (32)

1. J.M. Brown, and W.R. Wilson Exploiting tumour hypoxia in cancer treatment Nat. Rev. Cancer 4 2004 437 447
2. G.L. Semenza Intratumoral hypoxia, radiation resistance, and HIF-1 Cancer Cell 5 2004 405 406
3. S. Kizaka-Kondoh, M. Inoue, H. Harada, and M. Hiraoka Tumor hypoxia: a target for selective cancer therapy Cancer Sci. 94 2003 1021 1028
4. P.W. Hochachka, and G.N. Somero Biochemical Adaptation first ed. 2002 Oxford University Press New York
5. M.L. Turcotte, M. Parliament, A. Franko, and J. Allalunis-Turner Variation in mitochondrial function in hypoxia-sensitive and hypoxia-tolerant human glioma cells Br. J. Cancer 86 2002 619 624
6. J.P. Steinbach, A. Klumpp, H. Wolburg, and M. Weller Inhibition of epidermal growth factor receptor signaling protects human malignant glioma cells from hypoxia-induced cell death Cancer Res. 64 2004 1575 1578
7. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nat. Rev. Cancer 2 2002 489 501
8. M.A. Bjornsti, and P.J. Houghton The tor pathway: a target for cancer therapy Nat. Rev. Cancer 4 2004 335 348
9. A.M. Arsham, J.J. Howell, and M.C. Simon A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets J. Biol. Chem. 278 2003 29655 29660
10. S. Hiratsuka, K. Nakamura, S. Iwai, M. Murakami, T. Itoh, H. Kijima, J.M. Shipley, R.M. Senior, and M. Shibuya MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis Cancer Cell 2 2002 289 300
11. S. Shimizu, Y. Eguchi, W. Kamiike, Y. Itoh, J. Hasegawa, K. Yamabe, Y. Otsuki, H. Matsuda, and Y. Tsujimoto Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-XL Cancer Res. 56 1996 2161 2166
12. F. Imamura, K. Shinkai, M. Mukai, K. Yoshioka, R. Komagome, T. Iwasaki, and H. Akedo rho-Mediated protein tyrosine phosphorylation in lysophosphatidic-acid-induced tumor-cell invasion Int. J. Cancer 65 1996 627 632
13. Q.P. Weng, K. Andrabi, M.T. Kozlowski, J.R. Grove, and J. Avruch Multiple independent inputs are required for activation of the p70 S6 kinase Mol. Cell. Biol. 15 1995 2333 2340
14. R.B. Pearson, P.B. Dennis, J.W. Han, N.A. Williamson, S.C. Kozma, R.E. Wettenhall, and G. Thomas The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain EMBO J. 14 1995 5279 5287
15. M. Inoue, M. Mukai, Y. Hamanaka, M. Tatsuta, M. Hiraoka, and S. Kizaka-Kondoh Targeting hypoxic cancer cells with a protein prodrug is effective in experimental malignant ascites Int. J. Oncol. 25 2004 713 720
16. B.A. Scott, M.S. Avidan, and C.M. Crowder Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2 Science 296 2002 2388 2391
17. Y. Eguchi, S. Shimizu, and Y. Tsujimoto Intracellular ATP levels determine cell death fate by apoptosis or necrosis Cancer Res. 57 1997 1835 1840
18. C. Schmaltz, P.H. Hardenbergh, A. Wells, and D.E. Fisher Regulation of proliferation-survival decisions during tumor cell hypoxia Mol. Cell. Biol. 18 1998 2845 2854
19. S. Shimizu, Y. Eguchi, H. Kosaka, W. Kamiike, H. Matsuda, and Y. Tsujimoto Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL Nature 374 1995 811 813
20. A. Dufner, and G. Thomas Ribosomal S6 kinase signaling and the control of translation Exp. Cell Res. 253 1999 100 109
21. A. Takano, I. Usui, T. Haruta, J. Kawahara, T. Uno, M. Iwata, and M. Kobayashi Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin Mol. Cell. Biol. 21 2001 5050 5062
22. F. Tremblay, and A. Marette Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells J. Biol. Chem. 276 2001 38052 38060
23. K. Inoki, T. Zhu, and K.L. Guan TSC2 mediates cellular energy response to control cell growth and survival Cell 115 2003 577 590
24. J.S. Britton, W.K. Lockwood, L. Li, S.M. Cohen, and B.A. Edgar Drosophila's insulin/PI3-kinase pathway coordinates cellular metabolism with nutritional conditions Dev. Cell 2 2002 239 249
25. M.B. Atkins, M. Hidalgo, W.M. Stadler, T.F. Logan, J.P. Dutcher, G.R. Hudes, Y. Park, S.H. Liou, B. Marshall, J.P. Boni, G. Dukart, and M.L. Sherman Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma J. Clin. Oncol. 22 2004 909 918
26. A. Boulay, S. Zumstein-Mecker, C. Stephan, I. Beuvink, F. Zilbermann, R. Haller, S. Tobler, C. Heusser, T. O'Reilly, B. Stolz, A. Marti, G. Thomas, and H.A. Lane Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells Cancer Res. 64 2004 252 261
27. R.E. Durand, and J.A. Raleigh Identification of nonproliferating but viable hypoxic tumor cells in vivo Cancer Res. 58 1998 3547 3550
28. H. Esumi, K. Izuishi, K. Kato, K. Hashimoto, Y. Kurashima, A. Kishimoto, T. Ogura, and T. Ozawa Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5′-AMP-activated protein kinase-dependent manner J. Biol. Chem. 277 2002 32791 32798
29. H. Harada, M. Hiraoka, and S. Kizaka-Kondoh Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells Cancer Res. 62 2002 2013 2018
30. L.B. Gardner, Q. Li, M.S. Park, W.M. Flanagan, G.L. Semenza, and C.V. Dang Hypoxia inhibits G1/S transition through regulation of p27 expression J. Biol. Chem. 276 2001 7919 7926
31. H. Jiang, J. Coleman, R. Miskimins, and W.K. Miskimins Expression of constitutively active 4EBP-1 enhances p27Kip1 expression and inhibits proliferation of MCF7 breast cancer cells Cancer Cell Int. 3 2003 2
32. A. Masuda, H. Osada, Y. Yatabe, K. Kozaki, Y. Tatematsu, T. Takahashi, and T. Hida Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments Am. J. Pathol. 158 2001 87 96